Skip to main content

Advertisement

Open Peer Review Reports for: Efficacy of sorafenib, a multi-tyrosine kinase inhibitor, in an adenoid cystic carcinoma metastatic to the lung: case report and review of literature

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
1 Mar 2011 Submitted Original manuscript
28 Mar 2011 Reviewed Reviewer Report - NICHOLAS SLEVIN
11 Apr 2011 Reviewed Reviewer Report - Marcelo Blaya
10 May 2011 Author responded Author comments - Daniel Dammrich
Resubmission - Version 2
10 May 2011 Submitted Manuscript version 2
31 May 2011 Reviewed Reviewer Report - NICHOLAS SLEVIN
31 May 2011 Reviewed Reviewer Report - Marcelo Blaya
9 Jul 2011 Author responded Author comments - Daniel Dammrich
Resubmission - Version 3
9 Jul 2011 Submitted Manuscript version 3
22 Jul 2011 Author responded Author comments - Daniel Dammrich
Resubmission - Version 4
22 Jul 2011 Submitted Manuscript version 4
26 Jul 2011 Author responded Author comments - Daniel Dammrich
Resubmission - Version 5
26 Jul 2011 Submitted Manuscript version 5
7 Aug 2011 Author responded Author comments - Daniel Dammrich
Resubmission - Version 6
7 Aug 2011 Submitted Manuscript version 6
10 Aug 2011 Author responded Author comments - Daniel Dammrich
Resubmission - Version 7
10 Aug 2011 Submitted Manuscript version 7
Publishing
27 Sep 2011 Editorially accepted
27 Sep 2011 Article published 10.1186/1752-1947-5-483

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement